AbbVie Inc. (ABBV) vs Amazon.com, Inc. (AMZN)

See how AbbVie Inc. and Amazon.com, Inc. differ across market data and performance, so you can decide which asset best fits your strategy.

$256.42
NYSE
AbbVie Inc. is a pharmaceutical company with significant exposure to immunology through Humira, Skyrizi, and Rinvoq, and to oncology through Imbruvica and Venclexta. The company was spun off from Abbott in early 2013. Its 2020 acquisition of Allergan expanded its portfolio with additional products in aesthetics, including Botox. In 2024, AbbVie further strengthened its business through the acquisitions of Cerevel in neuroscience and ImmunoGen in oncology.
View Full Page
$259.77
NasdaqGS
Amazon.com Inc. is a leading global e-commerce retailer and marketplace for third-party sellers. Retail-related operations account for about 74% of total revenue, followed by Amazon Web Services at 17% and advertising services at 9%. International business represents 22% of overall revenue, with Germany, the United Kingdom, and Japan serving as the company’s largest foreign markets.
View Full Page

Key Metrics Comparison

AbbVie Inc.ABBV
Market Cap
$453.124B
Price
$256.42
24h Change
+0.37%
24h Volume
$4.24M
Employees
57,000
Shares Outstanding
1,768,169,012
Amazon.com, Inc.AMZN
Market Cap
$2.802T
Price
$259.77
24h Change
-2.50%
24h Volume
$45.42M
Employees
1,575,000
Shares Outstanding
10,757,109,436

Category Performance

Visual comparison across key categories. Ring fill represents relative strength or share between the two assets.

Market Share

Share of combined market cap

Market Share
ABBV
13.9%
AMZN
86.1%

Volume Share

Share of combined 24h volume

Volume Share
ABBV
8.5%
AMZN
91.5%

24h Performance

Price change over last 24 hours

24h Performance
ABBV
0.37%
AMZN
-2.50%
Price Comparison
AbbVie Inc.
Amazon.com, Inc.